ATM-IN-13 (A36) is an orally active, selective ATM kinase inhibitor with a human IC 50 of 0.3 nM. ATM-IN-13 blocks the ATM -mediated DNA double-strand break repair signaling pathway, reduces the phosphorylation levels of ATM and p53 , and inhibits ATM -dependent DNA damage response. ATM-IN-13 can be used in the research of colorectal cancer .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > ATM/ATR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.